IRIS Accounts Production v25.1.0.734 08913988 Board of Directors 29.2.24 28.2.25 28.2.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 219 144696 8502 9990 16588 154905 8305 219 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089139882024-02-28089139882025-02-28089139882024-02-292025-02-28089139882023-02-28089139882023-03-012024-02-28089139882024-02-2808913988ns15:EnglandWales2024-02-292025-02-2808913988ns14:PoundSterling2024-02-292025-02-2808913988ns10:Director12024-02-292025-02-2808913988ns10:PrivateLimitedCompanyLtd2024-02-292025-02-2808913988ns10:SmallEntities2024-02-292025-02-2808913988ns10:AuditExempt-NoAccountantsReport2024-02-292025-02-2808913988ns10:SmallCompaniesRegimeForDirectorsReport2024-02-292025-02-2808913988ns10:SmallCompaniesRegimeForAccounts2024-02-292025-02-2808913988ns10:FullAccounts2024-02-292025-02-2808913988ns10:OrdinaryShareClass12024-02-292025-02-2808913988ns10:OrdinaryShareClass22024-02-292025-02-2808913988ns10:OrdinaryShareClass32024-02-292025-02-2808913988ns10:Director2422024-02-2808913988ns10:Director2422023-02-2808913988ns10:Director2422024-02-292025-02-2808913988ns10:Director2422023-03-012024-02-2808913988ns10:Director2422025-02-2808913988ns10:Director2422024-02-2808913988ns5:CurrentFinancialInstruments2025-02-2808913988ns5:CurrentFinancialInstruments2024-02-2808913988ns5:Non-currentFinancialInstruments2025-02-2808913988ns5:Non-currentFinancialInstruments2024-02-2808913988ns5:ShareCapital2025-02-2808913988ns5:ShareCapital2024-02-2808913988ns5:RetainedEarningsAccumulatedLosses2025-02-2808913988ns5:RetainedEarningsAccumulatedLosses2024-02-2808913988ns10:RegisteredOffice2024-02-292025-02-2808913988ns5:FurnitureFittings2024-02-292025-02-2808913988ns5:FurnitureFittings2024-02-2808913988ns5:FurnitureFittings2025-02-2808913988ns5:FurnitureFittings2024-02-2808913988ns5:WithinOneYearns5:CurrentFinancialInstruments2025-02-2808913988ns5:WithinOneYearns5:CurrentFinancialInstruments2024-02-2808913988ns5:DeferredTaxation2024-02-2808913988ns5:DeferredTaxation2024-02-292025-02-2808913988ns5:DeferredTaxation2025-02-2808913988ns10:OrdinaryShareClass12025-02-2808913988ns10:OrdinaryShareClass22025-02-2808913988ns10:OrdinaryShareClass32025-02-2808913988ns10:Director22024-02-292025-02-28089139881ns10:Director12024-02-28089139881ns10:Director12023-02-28089139881ns10:Director12024-02-292025-02-28089139881ns10:Director12023-03-012024-02-28089139881ns10:Director12025-02-28089139881ns10:Director12024-02-28
REGISTERED NUMBER: 08913988 (England and Wales)















Unaudited Financial Statements for the Year Ended 28 February 2025

for

Medix Direct Ltd

Medix Direct Ltd (Registered number: 08913988)






Contents of the Financial Statements
for the Year Ended 28 February 2025




Page

Balance Sheet 1

Notes to the Financial Statements 3


Medix Direct Ltd (Registered number: 08913988)

Balance Sheet
28 February 2025

28.2.25 28.2.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,998 1,305

CURRENT ASSETS
Debtors 5 502,456 503,035
Cash at bank 191,567 219,628
694,023 722,663
CREDITORS
Amounts falling due within one year 6 6,219 10,360
NET CURRENT ASSETS 687,804 712,303
TOTAL ASSETS LESS CURRENT
LIABILITIES

690,802

713,608

CREDITORS
Amounts falling due after more than one
year

7

(240

)

(362

)

PROVISIONS FOR LIABILITIES 8 (570 ) (248 )
NET ASSETS 689,992 712,998

CAPITAL AND RESERVES
Called up share capital 9 62 62
Retained earnings 689,930 712,936
SHAREHOLDERS' FUNDS 689,992 712,998

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Medix Direct Ltd (Registered number: 08913988)

Balance Sheet - continued
28 February 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 June 2025 and were signed on its behalf by:





Dr A Al-Kayssi - Director


Medix Direct Ltd (Registered number: 08913988)

Notes to the Financial Statements
for the Year Ended 28 February 2025

1. STATUTORY INFORMATION

Medix Direct Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 08913988

Registered office: C/o Echo Tax, SPACES Manchester
Peter House
Oxford
Manchester
M1 5AN

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2024 - 3 ) .

Medix Direct Ltd (Registered number: 08913988)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 29 February 2024 1,740
Additions 2,637
At 28 February 2025 4,377
DEPRECIATION
At 29 February 2024 435
Charge for year 944
At 28 February 2025 1,379
NET BOOK VALUE
At 28 February 2025 2,998
At 28 February 2024 1,305

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 28.2.24
£    £   
Trade debtors - 1,059
Amounts owed by associates 502,456 501,976
502,456 503,035

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
28.2.25 28.2.24
£    £   
Tax (3,646 ) 8,617
Social security and other taxes (1 ) 80
Other creditors 1,081 724
Directors' current accounts 8,305 219
Accrued expenses 480 720
6,219 10,360

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
28.2.25 28.2.24
£    £   
Other creditors 240 362

8. PROVISIONS FOR LIABILITIES
28.2.25 28.2.24
£    £   
Deferred tax 570 248

Medix Direct Ltd (Registered number: 08913988)

Notes to the Financial Statements - continued
for the Year Ended 28 February 2025

8. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 29 February 2024 248
Provided during year 322
Balance at 28 February 2025 570

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 28.2.25 28.2.24
value: £    £   
60 Ordinary A 1 60 60
1 Ordinary B 1 1 1
1 Ordinary C 1 1 1
62 62

Ordinary A shares - These shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

Ordinary B and C shares - Each share has no voting rights, no distribution and no wind up rights. Each share has a right to dividends at the discretion of the "A" shareholders.

10. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 28 February 2025 and 28 February 2024:

28.2.25 28.2.24
£    £   
Dr A Al-Kayssi and Dr S M Abbas
Balance outstanding at start of year (219 ) 144,696
Amounts advanced 8,502 9,990
Amounts repaid (16,588 ) (154,905 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (8,305 ) (219 )

11. ULTIMATE CONTROLLING PARTY

The controlling party is Dr A Al-Kayssi.